收费全文 | 2347篇 |
免费 | 87篇 |
国内免费 | 7篇 |
耳鼻咽喉 | 37篇 |
儿科学 | 110篇 |
妇产科学 | 18篇 |
基础医学 | 194篇 |
口腔科学 | 36篇 |
临床医学 | 152篇 |
内科学 | 534篇 |
皮肤病学 | 34篇 |
神经病学 | 114篇 |
特种医学 | 75篇 |
外科学 | 491篇 |
综合类 | 65篇 |
预防医学 | 123篇 |
眼科学 | 157篇 |
药学 | 129篇 |
中国医学 | 9篇 |
肿瘤学 | 163篇 |
2023年 | 15篇 |
2022年 | 42篇 |
2021年 | 104篇 |
2020年 | 48篇 |
2019年 | 71篇 |
2018年 | 80篇 |
2017年 | 58篇 |
2016年 | 70篇 |
2015年 | 68篇 |
2014年 | 107篇 |
2013年 | 128篇 |
2012年 | 214篇 |
2011年 | 191篇 |
2010年 | 121篇 |
2009年 | 104篇 |
2008年 | 165篇 |
2007年 | 145篇 |
2006年 | 124篇 |
2005年 | 102篇 |
2004年 | 85篇 |
2003年 | 79篇 |
2002年 | 89篇 |
2001年 | 16篇 |
2000年 | 14篇 |
1999年 | 25篇 |
1998年 | 5篇 |
1997年 | 6篇 |
1996年 | 7篇 |
1995年 | 10篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 9篇 |
1991年 | 10篇 |
1990年 | 11篇 |
1989年 | 9篇 |
1988年 | 7篇 |
1987年 | 5篇 |
1985年 | 4篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 4篇 |
1972年 | 10篇 |
1970年 | 4篇 |
1969年 | 4篇 |
1968年 | 4篇 |
1967年 | 4篇 |
1966年 | 10篇 |
1965年 | 3篇 |
1962年 | 4篇 |
1946年 | 4篇 |
Methods: This retrospective, non-randomized, interventional comparative study included 38 eyes of 38 patients. All cases underwent PPV with silicone oil tamponade. The main outcome measure was improvement of final visual acuity relative to the presenting visual acuity and factors affecting the same Group A included eyes with favorable vision of 20/400 or better and Group B included the others.
Results: Group A included 16 eyes (42.10%), group B included 22 eyes (57.89%). In Group A 2 eyes out of 16 (12.5%) and in Group B 12 eyes out of 22 (54.54%) had RRD at presentation (p = 0.02, 95% CI for the difference 7.88–65.78%). The time interval between first presentation and development of RRD in Group A was 30.94 ± 38.8 days (median 30 days) whereas that in Group B was 10.81 ± 11.73 days (median 8 days) (p = 0.02). The odds of visual improvement post-vitrectomy when RRD occurred later was 8.4 (p = 0.01, 95% CI 1.53–46.1). The usage of systemic steroids (odds 5.2, p = 0.03, 95% CI 1.14–23.54) and oral valacyclovir (odds 4.33, p = 0.04, 95% CI 1.05–17.84) were associated with odds favoring a good visual outcome. Recurrent RRD was noted in 3/16 eyes (18.75%) in Group A and 13/22 eyes (59.09%) in Group B (p = 0.03).
Conclusion: Delayed occurrence of RRD after ARN is a good prognostic factor. Usage of systemic steroids and oral valacylocvir are associated with a favorable visual outcome when started before the onset of RRD. 相似文献
While there is evidence of morbidity compression in many countries, temporal patterns of non-communicable diseases (NCDs) in developing countries, such as India, are less clear. Age at onset of disease offers insights to understanding epidemiologic trends and is a key input for public health programs. Changes in age at onset and duration of major NCDs were estimated for 2004 (n = 38,044) and 2018 (n = 43,239) using health surveys from the India National Sample Survey (NSS). Survival regression models were used to compare trends by sociodemographic characteristics. Comparing 2004 to 2018, there were reductions in age at onset and increases in duration for overall and cause-specific NCDs. Median age at onset decreased for NCDs overall (57 to 53 years) and for diabetes, hypertension, heart disease, asthma, mental diseases, eye disease, and bone disease in the range of 2–7 years and increased for cancer, neurological disorders, some genitourinary disorders, and injuries/accidents in the range of 2–14 years. Hazards of NCDs were higher among females for cancers (HR 1.51, 95% CI 1.19–1.90) and neurological disorders (HR 1.18, 95% CI 1.06–1.32) but lower for heart diseases (HR 0.88, 95% CI 0.79–0.97) and injuries/accidents (HR 0.87, 95% CI 0.77–0.99). Hazards were greater among those with lower educational attainment at younger ages and higher educational attainment later in life. Unlike many countries, chronic disease morbidity may be expanding in India for many chronic diseases, indicating excess strain on the health system. Public health programs should focus on early diagnosis and prevention of NCDs.
相似文献